Skip to content
10-Q

Quarterly Report

LUMOS PHARMA, INC.

0001126234-24-000088

← back to feed
Filed
Aug 2, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 26, 2024 8.12M sh
Shares Diluted Q2 2024 · Jun 30, 2024 8.11M sh
Shares Diluted Q2 2024 · Jun 30, 2024 8.11M sh
Shares Diluted Q2 2024 · Jun 30, 2023 8.16M sh
Shares Diluted Q2 2024 · Jun 30, 2023 8.21M sh
Stock Repurchased Q2 2024 · Jun 30, 2024 $0
Stock Repurchased Q2 2024 · Jun 30, 2023 $884K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$19.27M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$15.88M
Short Term Investments Q2 2024 · Jun 30, 2024 $0
Short Term Investments Q2 2024 · Dec 31, 2023 $999K
Cash And Equivalents Q2 2024 · Jun 30, 2024 $16.8M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $35.08M
Stockholders Equity Q2 2024 · Jun 30, 2024 $10.28M
Stockholders Equity Q2 2024 · Mar 31, 2024 $17.44M
Stockholders Equity Q2 2024 · Dec 31, 2023 $27.31M
Stockholders Equity Q2 2024 · Jun 30, 2023 $43.66M
Stockholders Equity Q2 2024 · Mar 31, 2023 $52.52M
Stockholders Equity Q2 2024 · Dec 31, 2022 $59.58M
Current Liabilities Q2 2024 · Jun 30, 2024 $4.94M
Current Liabilities Q2 2024 · Dec 31, 2023 $7.03M
Total Liabilities Q2 2024 · Jun 30, 2024 $11.08M
Total Liabilities Q2 2024 · Dec 31, 2023 $13.33M
Current Assets Q2 2024 · Jun 30, 2024 $20.89M
Current Assets Q2 2024 · Dec 31, 2023 $40.04M
Total Assets Q2 2024 · Jun 30, 2024 $21.36M
Total Assets Q2 2024 · Dec 31, 2023 $40.64M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.93
Eps Diluted Q2 2024 · Jun 30, 2024 −$2.22
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.09
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.98
Eps Basic Q2 2024 · Jun 30, 2024 −$0.93
Eps Basic Q2 2024 · Jun 30, 2024 −$2.22
Eps Basic Q2 2024 · Jun 30, 2023 −$1.09
Eps Basic Q2 2024 · Jun 30, 2023 −$1.98
Sga Expense Q2 2024 · Jun 30, 2024 $3.68M
Sga Expense Q2 2024 · Jun 30, 2024 $7.46M
Sga Expense Q2 2024 · Jun 30, 2023 $4.15M
Sga Expense Q2 2024 · Jun 30, 2023 $8.5M
Rd Expense Q2 2024 · Jun 30, 2024 $4.63M
Rd Expense Q2 2024 · Jun 30, 2024 $11.88M
Rd Expense Q2 2024 · Jun 30, 2023 $6.02M
Rd Expense Q2 2024 · Jun 30, 2023 $10.39M
Net Income Q2 2024 · Jun 30, 2024 −$7.55M
Net Income Q2 2024 · Jun 30, 2024 −$17.99M
Net Income Q2 2024 · Mar 31, 2024 −$10.44M
Net Income Q2 2024 · Jun 30, 2023 −$8.93M
Net Income Q2 2024 · Jun 30, 2023 −$16.28M
Net Income Q2 2024 · Mar 31, 2023 −$7.35M
Operating Income Q2 2024 · Jun 30, 2024 −$7.82M
Operating Income Q2 2024 · Jun 30, 2024 −$18.69M
Operating Income Q2 2024 · Jun 30, 2023 −$9.64M
Operating Income Q2 2024 · Jun 30, 2023 −$17.68M
Revenue Q2 2024 · Jun 30, 2024 $488K
Revenue Q2 2024 · Jun 30, 2024 $653K
Revenue Q2 2024 · Jun 30, 2023 $527K
Revenue Q2 2024 · Jun 30, 2023 $1.22M